3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Conditions
Endometrial Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Breast Neoplasms
4
Prostatic Neoplasms
3
Lung Neoplasms
3
Leukemia, Myeloid, Acute
3
Urinary Bladder Neoplasms
2
Rectal Neoplasms
2
Ovarian Neoplasms
2
Neoplasm Metastasis
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia
2
Colonic Neoplasms
2
Carcinoma, Intraductal, Noninfiltrating
2
Vulvar Neoplasms
1
Uterine Cervical Neoplasms
1
Ureteral Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Smoldering Multiple Myeloma
1
Small Cell Lung Carcinoma
1
Skin Neoplasms
1
Retinoblastoma
1
Peritoneal Neoplasms
1
Pathologic Complete Response
1
Pancreatic Neoplasms
1
Oropharyngeal Neoplasms
1
Neuroblastoma
1
Neoplasms
1
Mouth Neoplasms
1
Interventions
Paclitaxel
3
Cytoreduction Surgical Procedures
2
tremelimumab
1
soluble LAG-3 protein, human
1
sodium thiosulfate
1
relacorilant
1
oregovomab
1
olaparib
1
avelumab
1
Taxes
1
Observation
1
Leucovorin
1
Hyperthermic Intraperitoneal Chemotherapy
1
Fluorouracil
1
Cisplatin
1
Cell Count
1
Carboplatin
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Peritoneal Neoplasms
×
Observation
×
Clear all
NCT02113384
2021-07-28
LARC-EX
Oslo University Hospital
Active not recruiting
231 enrolled